Roivant Sciences (ROIV) Debt Ratio (2021 - 2024)
Roivant Sciences (ROIV) posted Debt Ratio of 0.05 for Q2 2024, down 18.68% on a QoQ basis from 0.06 in Q1 2024, and down 72.87% year-over-year from 0.18 in Q3 2023.
Roivant Sciences (ROIV) Debt Ratio (2021 - 2024) Analysis & Trends
Roivant Sciences' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.05 for Q2 2024.
- Quarterly Debt Ratio fell 72.87% year-over-year to 0.05 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 0.05 (down 72.87% YoY) and the FY2024 annual result came in at 0.06, down 64.82% from the prior year.
- Debt Ratio was 0.05 for Q2 2024 at Roivant Sciences, down from 0.06 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.21 in Q3 2023 and bottomed at 0.05 in Q2 2024.
- A 4-year average of 0.11 and a median of 0.08 in 2021 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio surged 173.8% — and 2024, when it sank 72.87%.
- Roivant Sciences' Debt Ratio stood at 0.07 in 2021, then surged by 147.34% to 0.18 in 2022, then plunged by 67.73% to 0.06 in 2023, then fell by 14.34% to 0.05 in 2024.
- Business Quant data shows ROIV's Debt Ratio at 0.05 in Q2 2024, 0.06 in Q1 2024, and 0.06 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.18 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.18 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2021 | 0.07 |